Cargando…
Commentary – Do the negative results of the PENUT trial close the book on erythropoietin for premature infant brain?
Autor principal: | Volpe, Joseph J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369037/ https://www.ncbi.nlm.nih.gov/pubmed/32333558 http://dx.doi.org/10.3233/NPM-200444 |
Ejemplares similares
-
Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial
por: Wood, Thomas R., et al.
Publicado: (2021) -
Acute Kidney Injury Defined by Fluid-Corrected Creatinine in Premature Neonates: A Secondary Analysis of the PENUT Randomized Clinical Trial
por: Starr, Michelle C., et al.
Publicado: (2023) -
Commentary – Marijuana use during pregnancy and premature birth: A problem likely to worsen
por: Volpe, Joseph J.
Publicado: (2020) -
Endogenous erythropoietin concentrations and association with retinopathy of prematurity and brain injury in preterm infants
por: Fahim, Nancy M., et al.
Publicado: (2021) -
Iron and zinc: Nutrients with potential for neurorestoration in premature infants with cerebral white matter injury
por: Volpe, Joseph J.
Publicado: (2020)